Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Rees, Lesley" or (type exact bookEditor and editor="Rees, Lesley")

Add to list
- Journal Article
- A1
- open access
Assessment of nutritional status in children with kidney diseases : clinical practice recommendations from the Pediatric Renal Nutrition Taskforce

Christina L. Nelms, Vanessa Shaw, Larry A. Greenbaum, Caroline Anderson, An Desloovere (UGent) , Dieter Haffner, Michiel J. S. Oosterveld, Fabio Paglialonga, Nonnie Polderman, Leila Qizalbash, et al.

(2021) PEDIATRIC NEPHROLOGY. 36(4). p.995-1010
Add to list
- Journal Article
- A1
- open access
Energy and protein requirements for children with CKD stages 2-5 and on dialysis-clinical practice recommendations from the Pediatric Renal Nutrition Taskforce

Vanessa Shaw, Nonnie Polderman, José Renken-Terhaerdt, Fabio Paglialonga, Michiel Oosterveld, Jetta Tuokkola, Caroline Anderson, Ann Desloovere (UGent) , Laurence Greenbaum, Dieter Haffner, et al.

(2020) PEDIATRIC NEPHROLOGY. 35(3). p.519-531
Add to list
- Journal Article
- A1
- open access
The dietary management of calcium and phosphate in children with CKD stages 2-5 and on dialysis : clinical practice recommendation from the Pediatric Renal Nutrition Taskforce

Louise McAlister, Pearl Pugh, Laurence Greenbaum, Dieter Haffner, Lesley Rees, Caroline Anderson, An Desloovere (UGent) , Christina Nelms, Michiel Oosterveld, Fabio Paglialonga, et al.

(2020) PEDIATRIC NEPHROLOGY. 35(3). p.501-518
Add to list
- Journal Article
- A1
- open access
Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome

Larry A Greenbaum, Marc Fila, Gianluigi Ardissino, Samhar I Al-Akash, Jonathan Evans, Paul Henning, Kenneth V Lieberman, Silvio Maringhini, Lars Pape, Lesley Rees, et al.

(2016) KIDNEY INTERNATIONAL. 89(3). p.701-711
Add to list
- Conference Paper
- C3
- open access
Eculizumab (ECU) inhibits thrombotic microangiopathy (TMA) and improves renal function in pediatric patients (Pts) with atypical hemolytic uremic syndrome (aHUS)

Larry A Greenbaum, Marc Fila, Gianluigi Ardissino, Samhar I Al-Akash, Jonathan Evans, Paul Henning, Kenneth V Lieberman, Silvio Maringhini, Lars Pape, Lesley Rees, et al.

(2013) BLOOD. 122(21).
Add to list
- Conference Paper
- C3
- open access
Eculizumab inhibits thrombotic microangiopathy and improves renal function in pediatric patients with atypical hemolytic uremic syndrome

Larry Greenbaum, Marc Fila, Michel Tsimaratos, Gianluigi Ardissimo, Samhar I Al-Akash, Jonathan Evans, Paul Henning, Kenneth V Lieberman, Silvio Maringhini, Lars Pape, et al.

(2013) ASN Kidney Week, Abstracts.

Academic Bibliography

Assessment of nutritional status in children with kidney diseases : clinical practice recommendations from the Pediatric Renal Nutrition Taskforce

Energy and protein requirements for children with CKD stages 2-5 and on dialysis-clinical practice recommendations from the Pediatric Renal Nutrition Taskforce

The dietary management of calcium and phosphate in children with CKD stages 2-5 and on dialysis : clinical practice recommendation from the Pediatric Renal Nutrition Taskforce

Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome

Eculizumab (ECU) inhibits thrombotic microangiopathy (TMA) and improves renal function in pediatric patients (Pts) with atypical hemolytic uremic syndrome (aHUS)

Eculizumab inhibits thrombotic microangiopathy and improves renal function in pediatric patients with atypical hemolytic uremic syndrome

Contents

Support

Contact